Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Recruiting in Palo Alto (17 mi)
+13 other locations
LR
Overseen byLee Ratner, MD, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: AIDS Malignancy Consortium
No Placebo Group
Trial Summary
What is the purpose of this trial?
RATIONALE: Collecting and studying tissue samples from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies collecting tissue samples from patients with HIV-related malignancies.
Research Team
LR
Lee Ratner, MD, PhD
Principal Investigator
Washington University Siteman Cancer Center
Eligibility Criteria
Inclusion Criteria
Diffuse large B-cell lymphoma
Non-small cell lung malignancy
Absence of sufficient diagnostic tumor-biopsy tissue material to meet the protocol requirements for baseline specimen submission (minimum specimen size of 10 x 10 x 2 mm); repeat tumor biopsy will not be performed solely to meet the protocol specimen-collection requirements
See 5 more
Treatment Details
Interventions
- DNA Analysis (Genetic Analysis)
- Gene Expression Analysis (Genetic Analysis)
- Polymorphism Analysis (Genetic Analysis)
- RNA Analysis (Genetic Analysis)
Participant Groups
3Treatment groups
Experimental Treatment
Group I: HIV-positive lung cancer casesExperimental Treatment7 Interventions
Tissue collection for genomic sequencing from persons with a diagnosis of HIV and lung cancer.
Group II: HIV-positive diffuse large B-cell lymphoma casesExperimental Treatment7 Interventions
Tissue collection for genomic sequencing from persons with a diagnosis of HIV and diffuse large B-cell lymphoma.
Group III: HIV-positive cervical cancer casesExperimental Treatment0 Interventions
Tissue specimen collection from HIV positive patients with a diagnosis of cervical cancer
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of MiamiMiami, FL
Fox Chase Cancer CenterPhiladelphia, PA
George Washington UniversityWashington, United States
UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
AIDS Malignancy Consortium
Lead Sponsor
Trials
64
Patients Recruited
9,600+
National Cancer Institute (NCI)
Collaborator
Trials
14080
Patients Recruited
41,180,000+
The Emmes Company, LLC
Industry Sponsor
Trials
149
Patients Recruited
1,052,000+
AIDS and Cancer Specimen Resource
Collaborator
Trials
8
Patients Recruited
990+
University of Arkansas
Collaborator
Trials
500
Patients Recruited
153,000+